Staphylococcal Skin Infections clinical trials
The registry lists 30 studies for Staphylococcal Skin Infections across more than 10 countries. 0 are recruiting or about to start. 24 of them are mainly about Staphylococcal Skin Infections (how this is decided). Per ClinicalTrials.gov, last updated 2025-07-17. Counting its narrower condition Impetigo too: 60 studies, 3 open.
Who runs them
Basilea Pharmaceutica (6) · Washington University School of Medicine (3) · Forest Laboratories (2) · Cumberland Pharmaceuticals (2) · Melinta Therapeutics, Inc. (2) · Henry M. Jackson Foundation for the Advancement of Military Medicine (2) · Clinical Directors Network (1) · Theravance Biopharma (1)
What is being tested here
Drugs under test in Staphylococcal Skin Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Who these studies take
No Staphylococcal Skin Infections study is recruiting now.
Across all 30 studies, recruiting or not: 40% stop at 75 or younger and 37% at 65; 23% take children; 0% are for women only and 7% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 30 of 30. search them.
- Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer CandidatesCompletedNCT00475930Not applicable1 country
- Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSACompletedNCT02814916Phase 320 countries
- Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military TraineesCompletedNCT01105767Not applicable1 country
- TD-1792 in Gram-positive Complicated Skin and Skin Structure InfectionCompletedNCT00442832Phase 21 country
- Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin InfectionsCompletedNCT00948142Phase 21 country
- Individualized vs. Household MRSA DecolonizationCompletedNCT01814371Not applicable1 country
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedNCT00091819Phase 31 country
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedNCT00107978Phase 31 country
- Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSACompletedNCT01419184Phase 42 countries
- Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection RecurrenceStatus unknownNCT02566928Phase 41 country
- Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedNCT00424190Phase 311 countries
- Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedNCT00423657Phase 312 countries
- Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSACompletedNCT02582203Phase 41 country
- The Natural History of Community-Associated MRSA Infections and Decolonization StrategiesCompletedNCT00513799Not applicable1 country
- Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin InfectionsCompletedNCT00719810Phase 22 countries
- An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy AdultsCompletedNCT01018641Phase 11 country
- Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin InfectionsCompletedNCT00646958Phase 21 country
- Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin InfectionsCompletedNCT00352612Phase 41 country
- A Complicated Skin and Soft-tissue Infection Patient RegistryCompletedNCT00737269
- Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal DiseaseCompletedNCT01030731Phase 1
- A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese PatientsCompletedNCT01026558Phase 1
- Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy VolunteersCompletedNCT01026740Phase 1
- A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of AgeCompletedNCT01026636Phase 1
- Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure InfectionsCompletedNCT00228982Phase 3
- Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure InfectionsCompletedNCT00210899Phase 3
- Staphylococcus Aureus Decolonization StudyCompletedNCT00731783Not applicable1 country
- Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure InfectionsTerminatedNCT00463801Phase 41 country
- Rapid Test to Detect Staphylococcus Aureus in Blood and Wound InfectionsCompletedNCT011982621 country
- A Study for Patients With Complicated Skin and Skin Structure InfectionsCompletedNCT00514527Phase 26 countries
- First Time in Man Trial for Friulimicin BTerminatedNCT00492271Phase 11 country